106 related articles for article (PubMed ID: 9822907)
1. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1998 Oct; 124(1-2):99-107. PubMed ID: 9822907
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1998 Oct; 124(1-2):108-17. PubMed ID: 9822908
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulating hormone.
Heijmen PS; Klis SF; De Groot JC; Smoorenburg GF
Hear Res; 1999 Feb; 128(1-2):27-39. PubMed ID: 10082280
[TBL] [Abstract][Full Text] [Related]
4. Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig.
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):157-67. PubMed ID: 10831874
[TBL] [Abstract][Full Text] [Related]
5. Reversible cisplatin ototoxicity in the albino guinea pig.
Klis SF; O'Leary SJ; Hamers FP; De Groot JC; Smoorenburg GF
Neuroreport; 2000 Feb; 11(3):623-6. PubMed ID: 10718325
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1997 Sep; 111(1-2):103-13. PubMed ID: 9307316
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):135-46. PubMed ID: 10831872
[TBL] [Abstract][Full Text] [Related]
8. Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.
Hamers FP; Klis SF; Gispen WH; Smoorenburg GF
Eur Arch Otorhinolaryngol; 1994; 251(1):23-9. PubMed ID: 8179863
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):147-56. PubMed ID: 10831873
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
[TBL] [Abstract][Full Text] [Related]
11. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.
O'Leary SJ; Klis SF; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2001 Apr; 154(1-2):135-45. PubMed ID: 11423224
[TBL] [Abstract][Full Text] [Related]
12. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs.
Teranishi M; Nakashima T; Wakabayashi T
Hear Res; 2001 Jan; 151(1-2):61-70. PubMed ID: 11124452
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside.
Kong WJ; Ren T; Nuttall AL
Hear Res; 1996 Sep; 99(1-2):22-30. PubMed ID: 8970810
[TBL] [Abstract][Full Text] [Related]
15. Ototoxicity resulting from combined administration of cisplatin and gentamicin.
Riggs LC; Brummett RE; Guitjens SK; Matz GJ
Laryngoscope; 1996 Apr; 106(4):401-6. PubMed ID: 8614212
[TBL] [Abstract][Full Text] [Related]
16. Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose.
Klis SF; O'Leary SJ; Wijbenga J; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2002 Feb; 164(1-2):138-46. PubMed ID: 11950533
[TBL] [Abstract][Full Text] [Related]
17. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
[TBL] [Abstract][Full Text] [Related]
18. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.
van Ruijven MW; de Groot JC; Klis SF; Smoorenburg GF
Hear Res; 2005 Jul; 205(1-2):241-8. PubMed ID: 15953532
[TBL] [Abstract][Full Text] [Related]
19. Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.
Wolters FL; de Vocht TF; Klis SF; Hamers FP; Smoorenburg GF
Hear Res; 2002 Oct; 172(1-2):110-7. PubMed ID: 12361873
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of gentamicin on the distribution of cochlear function in albino and pigmented guinea pigs.
Conlee JW; Bennett ML; Creel DJ
Acta Otolaryngol; 1995 May; 115(3):367-74. PubMed ID: 7653256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
